Sara
Villar Fernández
Colaboradora Clínica
Publicaciones (18) Publicaciones de Sara Villar Fernández
2024
-
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC
Bone Marrow Transplantation
-
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Bone Marrow Transplantation, Vol. 59, Núm. 7, pp. 965-973
2023
-
Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
JCI Insight, Vol. 8, Núm. 2
-
Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440
-
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
Blood Advances, Vol. 7, Núm. 1, pp. 167-173
-
Low Rate of Infectious Enterocolitis in Allogeneic Stem Cell Transplant Recipients with Acute Diarrhea: A Prospective Study by the GETH-TC
Acta haematologica, Vol. 146, Núm. 2, pp. 161-165
-
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
Frontiers in Immunology, Vol. 14
-
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia
British Journal of Haematology
2022
-
Explainable artificial intelligence for precision medicine in acute myeloid leukemia
Frontiers in Immunology, Vol. 13
-
Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation
Transplantation and Cellular Therapy, Vol. 28, Núm. 10, pp. 703.e1-703.e8
-
Successful cefiderocol therapy of severe infections due to difficult-to-treat Pseudomonas aeruginosa in two allogeneic hematopoietic stem cell transplantation recipients
Annals of Hematology
-
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
Frontiers in Oncology, Vol. 12
-
Updates on the Management of Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 19
2021
-
Allogeneic Stem Cell Transplantation for MDS
Hemato, Vol. 2, Núm. 3, pp. 545-555
-
Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial
Blood Advances, Vol. 5, Núm. 3, pp. 760-770
2018
2012
-
Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 6, pp. 1453-1458
-
Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 10, pp. 2479-2486